A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC

Clinical trial NCT06826768 · RECRUITING

Trial details

NCT number: NCT06826768
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2025-07-09
Primary completion: 2027-05-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.